Oliver Lagore Vanvalin Investment Group Abb Vie Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $263 Million
- Q2 2025
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Abb Vie Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 2,454 shares of ABBV stock, worth $481,720. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,454
Previous 147
1569.39%
Holding current value
$481,720
Previous $26,000
1650.0%
% of portfolio
0.17%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,253Shares Held
1.27BCall Options Held
16.6MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA174MShares$34.1 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.7 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.7 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.08 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $347B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...